The Terminal Telomeric DNA Sequence Determines the Mechanism of Dysfunctional Telomere Fusion

Bailey, 2006, Telomeres, chromosome instability and cancer, Nucleic Acids Res., 34, 2408, 10.1093/nar/gkl303 Blackburn, 2000, Telomere states and cell fates, Nature, 408, 53, 10.1038/35040500 Blackburn, 2005, Telomerase and cancer: Kirk A. Landon–AACR prize for basic cancer research lecture, Mol. Cancer Res., 3, 477, 10.1158/1541-7786.MCR-05-0147 Broccoli, 1997, Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2, Nat. Genet., 17, 231, 10.1038/ng1097-231 Capper, 2007, The nature of telomere fusion and a definition of the critical telomere length in human cells, Genes Dev., 21, 2495, 10.1101/gad.439107 Denchi, 2007, Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1, Nature, 448, 1068, 10.1038/nature06065 Forstemann, 2003, Yeast telomerase is specialized for C/A-rich RNA templates, Nucleic Acids Res., 31, 1646, 10.1093/nar/gkg261 Guiducci, 2001, Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability, Oncogene, 20, 714, 10.1038/sj.onc.1204145 Hockemeyer, 2006, Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres, Cell, 126, 63, 10.1016/j.cell.2006.04.044 Kim, 2001, A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation, Proc. Natl. Acad. Sci. USA, 98, 7982, 10.1073/pnas.131211098 Letsolo, 2009, Fusion of short telomeres in human cells is characterized by extensive deletion and microhomology, and can result in complex rearrangements, Nucleic Acids Res., 38, 1841, 10.1093/nar/gkp1183 Li, 2004, Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA, Cancer Res., 64, 4833, 10.1158/0008-5472.CAN-04-0953 Loayza, 2004, DNA binding features of human POT1: a nonamer 5′-TAGGGTTAG-3′ minimal binding site, sequence specificity, and internal binding to multimeric sites, J. Biol. Chem., 279, 13241, 10.1074/jbc.M312309200 Lobachev, 2002, The Mre11 complex is required for repair of hairpin-capped double-strand breaks and prevention of chromosome rearrangements, Cell, 108, 183, 10.1016/S0092-8674(02)00614-1 Maringele, 2004, Telomerase- and recombination-independent immortalization of budding yeast, Genes Dev., 18, 2663, 10.1101/gad.316504 Markham, 2005, DINAMelt web server for nucleic acid melting prediction, Nucleic Acids Res., 33, W577, 10.1093/nar/gki591 Martin, 2005, Postreplicative joining of DNA double-strand breaks causes genomic instability in DNA-PKcs-deficient mouse embryonic fibroblasts, Cancer Res., 65, 10223, 10.1158/0008-5472.CAN-05-0932 Marusic, 1997, Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability, Mol. Cell. Biol., 17, 6394, 10.1128/MCB.17.11.6394 Mirkin, 2007, Replication fork stalling at natural impediments, Microbiol. Mol. Biol. Rev., 71, 13, 10.1128/MMBR.00030-06 Miyake, 2009, RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway, Mol. Cell, 36, 193, 10.1016/j.molcel.2009.08.009 Okuno, 2004, Structure of a palindromic amplicon junction implicates microhomology-mediated end joining as a mechanism of sister chromatid fusion during gene amplification, Nucleic Acids Res., 32, 749, 10.1093/nar/gkh244 Palm, 2008, How shelterin protects mammalian telomeres, Annu. Rev. Genet., 42, 301, 10.1146/annurev.genet.41.110306.130350 Podlevsky, 2008, The telomerase database, Nucleic Acids Res., 36, D339, 10.1093/nar/gkm700 Rivera, 2004, Processive utilization of the human telomerase template: lack of a requirement for template switching, J. Biol. Chem., 279, 53770, 10.1074/jbc.M407768200 Smogorzewska, 2002, DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2, Curr. Biol., 12, 1635, 10.1016/S0960-9822(02)01179-X Stohr, 2008, ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells, Cancer Res., 68, 5309, 10.1158/0008-5472.CAN-08-0504 Surovtseva, 2009, Conserved telomere maintenance component 1 interacts with STN1 and maintains chromosome ends in higher eukaryotes, Mol. Cell, 36, 207, 10.1016/j.molcel.2009.09.017 Tanaka, 2007, Intrastrand annealing leads to the formation of a large DNA palindrome and determines the boundaries of genomic amplification in human cancer, Mol. Cell. Biol., 27, 1993, 10.1128/MCB.01313-06 Tanaka, 2009, Palindromic gene amplification—an evolutionarily conserved role for DNA inverted repeats in the genome, Nat. Rev. Cancer, 9, 216, 10.1038/nrc2591 Teixeira, 2005, Telomere maintenance, function and evolution: the yeast paradigm, Chromosome Res., 13, 535, 10.1007/s10577-005-0999-0 VanHulle, 2007, Inverted DNA repeats channel repair of distant double-strand breaks into chromatid fusions and chromosomal rearrangements, Mol. Cell. Biol., 27, 2601, 10.1128/MCB.01740-06 Verdun, 2005, Functional human telomeres are recognized as DNA damage in G2 of the cell cycle, Mol. Cell, 20, 551, 10.1016/j.molcel.2005.09.024 Wang, 2008, Chromosome fusions following telomere loss are mediated by single-strand annealing, Mol. Cell, 31, 463, 10.1016/j.molcel.2008.05.028 Wu, 2006, Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres, Cell, 126, 49, 10.1016/j.cell.2006.05.037 Xu, 2004, Human Rif1 protein binds aberrant telomeres and aligns along anaphase midzone microtubules, J. Cell Biol., 167, 819, 10.1083/jcb.200408181 Xu, 2007, Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres, Mol. Cell, 28, 315, 10.1016/j.molcel.2007.10.005 Zou, 2009, Altered states of telomere deprotection and the two-stage mechanism of replicative aging, Mol. Cell. Biol., 29, 2390, 10.1128/MCB.01569-08 Zufferey, 1997, Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo, Nat. Biotechnol., 15, 871, 10.1038/nbt0997-871